Yau Kenneth

The PAUL Glaucoma Implant in the management of uveitic glaucoma-3-year follow-up.

To date, this study represents the first publication looking specifically at the efficacy and safety of the PGI in the management of complex uveitic glaucoma.

Preserflo MicroShunt in refractory glaucoma: multicentre european results with up to three years of follow-up.

In a real-world, multicentre setting, the Preserflo MicroShunt showed sustained IOP reduction and decreased medication use over 3 years, supporting its long-term safety and efficacy.